Pfizer is considering buying NextWave Pharmaceuticals, a company that develops a liquid attention deficit hyperactivity disorder drug. In the second quarter of 2012, Pfizer signed an option and merger agreement with NextWave and made a ...
Tags: Pfizer, NextWave Pharmaceuticals, deficit hyperactivity disorder drug
Pfizer has announced the completion of its purchase of a specialty pharmaceutical company NextWave Pharmaceuticals. Through the acquisition,Pfizer has gained exclusive North American commercialization rights to the FDA approved Quillivant ...
Tags: Pfizer, specialty pharmaceutical company, NextWave Pharmaceuticals